RhumbLine Advisers’s Sight Sciences SGHT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$263K Buy
48,549
+1,907
+4% +$8.78K ﹤0.01% 3149
2026
Q1
$176K Sell
46,642
-3,458
-7% -$18.7K ﹤0.01% 3186
2025
Q4
$397K Sell
50,100
-4,211
-8% -$26.9K ﹤0.01% 2802
2025
Q3
$187K Sell
54,311
-286
-0.5% -$1.06K ﹤0.01% 3257
2025
Q2
$225K Buy
54,597
+4,800
+10% +$16K ﹤0.01% 3163
2025
Q1
$120K Buy
49,797
+4,319
+9% +$12.2K ﹤0.01% 3328
2024
Q4
$166K Buy
45,478
+1,104
+2% +$5.03K ﹤0.01% 3294
2024
Q3
$280K Buy
44,374
+3,563
+9% +$24K ﹤0.01% 3062
2024
Q2
$272K Buy
40,811
+11,671
+40% +$69K ﹤0.01% 3058
2024
Q1
$154K Buy
29,140
+1,318
+5% +$6.2K ﹤0.01% 3289
2023
Q4
$144K Hold
27,822
﹤0.01% 3330
2023
Q3
$93.8K Sell
27,822
-304
-1% -$2K ﹤0.01% 3484
2023
Q2
$233K Sell
28,126
-4,727
-14% -$42.6K ﹤0.01% 3159
2023
Q1
$287K Buy
32,853
+845
+3% +$9.38K ﹤0.01% 2628
2022
Q4
$391K Buy
32,008
+300
+0.9% +$2.85K ﹤0.01% 2586
2022
Q3
$201K Buy
31,708
+1,881
+6% +$15.9K ﹤0.01% 2893
2022
Q2
$268K Buy
29,827
+12,115
+68% +$107K ﹤0.01% 2815
2022
Q1
$205K Buy
+17,712
New +$273K ﹤0.01% 2753

Other funds holding SGHT

RhumbLine Advisers's SGHT Position: Q2 2026 in Review

RhumbLine Advisers increased its Sight Sciences (SGHT) stake by 4.1% in Q2 2026, buying an estimated $8.78K and bringing the position to 48,549 shares worth $263K. The position accounts for ﹤0.01% of the portfolio, ranked #3149.

RhumbLine Advisers first reported a position in SGHT in Q1 2022 and has held it in 18 quarters since. The position peaked at $397K in Q4 2025. 112 funds tracked by Wall St. Rank hold SGHT as of Q2 2026.

  • RhumbLine Advisers held 48,549 shares of Sight Sciences worth $263K as of Q2 2026.
  • RhumbLine Advisers bought 1,907 Sight Sciences shares in Q2 2026, an estimated $8.78K.
  • Sight Sciences made up ﹤0.01% of RhumbLine Advisers's portfolio in Q2 2026, its #3149 holding.
  • RhumbLine Advisers first reported a position in Sight Sciences in Q1 2022 and has held it in 18 quarters since.
  • RhumbLine Advisers's Sight Sciences position peaked at $397K in Q4 2025.
  • 112 funds tracked by Wall St. Rank held Sight Sciences as of Q2 2026.

Based on RhumbLine Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.